• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6个单核苷酸多态性升高低密度脂蛋白胆固醇多基因风险评分在阿根廷人群中具有家族性高胆固醇血症表型个体中的应用。

Application of the 6-SNP elevated LDL-cholesterol polygenic risk score in individuals with familial hypercholesterolemia phenotype from an Argentine population.

作者信息

Bañares Virginia, Martini Javier, López Graciela, Corral Pablo, Schreier Laura

机构信息

Administración Nacional de Laboratorios e Institutos de Salud "Dr Carlos Malbrán", Centro Nacional de Genética Médica, Departamento de Genética Experimental, Ciudad Autónoma de Buenos Aires.

Administración Nacional de Laboratorios e Institutos de Salud "Dr Carlos Malbrán", Centro Nacional de Genética Médica, Departamento de Genética Clínica, Ciudad Autónoma de Buenos Aires.

出版信息

Gac Med Mex. 2024;160(4):413-419. doi: 10.24875/GMM.M24000918.

DOI:10.24875/GMM.M24000918
PMID:39832338
Abstract

INTRODUCTION

LDL-cholesterol greater than 190 mg/dL indicates severe hypercholesterolemia (HS) of monogenic and/or polygenic origin. Genetic risk scores (GRS) evaluate potential polygenic causes.

OBJECTIVE

we applied a GRS of 6-SNP (GRS-6) in HS individuals.

MATERIAL AND METHODS

69 subjects from the Familial Hypercholesterolemia (HF) Detection registry in Argentina (Da Vinci).

RESULTS

with 44 individuals with HF-phenotype, not carriers of genetic variants that indicate a monogenic origin (HF/M-) and 26 controls, the GRS-6 cut-off value was established, > 0.76, sensitivity 0.59, specificity 0.69. 15/44(34 %) HF/M- presented GRS-6+. The mean GRS-6 values in HF/M-, HF/M+ and controls were 0.72 ± 0.17, 0.66 ± 0.17, and 0.70 ± 0.13 respectively (p = 0.43). There were no significant differences in cholesterol values, or in the clinical score, between cases with positive vs negative GRS-6. The GRS-6 was positive in 32 % of the cases vs 20 % of the previously applied GRS-10 (p = 0.003), significantly increasing the detection of polygenic contribution.

CONCLUSIONS

We present an estimate of the first cut-off value for the GRS-6 in a Latin American population, and we conclude that the GRS-6 could contribute to the evaluation of the polygenic contribution in cases with severe hypercholesterolemia in our population in a similar way to that of other European populations.

摘要

引言

低密度脂蛋白胆固醇大于190mg/dL表明存在单基因和/或多基因来源的严重高胆固醇血症(HS)。遗传风险评分(GRS)评估潜在的多基因病因。

目的

我们在HS个体中应用了6个单核苷酸多态性的遗传风险评分(GRS-6)。

材料与方法

来自阿根廷家族性高胆固醇血症(HF)检测登记处(达芬奇)的69名受试者。

结果

44名具有HF表型的个体,不是表明单基因来源的遗传变异携带者(HF/M-),以及26名对照,确定了GRS-6的临界值,>0.76,敏感性0.59,特异性0.69。15/44(34%)的HF/M-表现为GRS-6阳性。HF/M-、HF/M+和对照组的GRS-6平均值得分分别为0.72±0.17、0.66±0.17和0.70±0.13(p=0.43)。GRS-6阳性与阴性的病例在胆固醇值或临床评分上没有显著差异。GRS-6在32%的病例中呈阳性,而之前应用的GRS-10在20%的病例中呈阳性(p=0.003),显著增加了多基因贡献的检测率。

结论

我们给出了拉丁美洲人群中GRS-6的首个临界值估计,并且得出结论,GRS-6可以以与其他欧洲人群类似的方式,有助于评估我们人群中严重高胆固醇血症病例的多基因贡献。

相似文献

1
Application of the 6-SNP elevated LDL-cholesterol polygenic risk score in individuals with familial hypercholesterolemia phenotype from an Argentine population.6个单核苷酸多态性升高低密度脂蛋白胆固醇多基因风险评分在阿根廷人群中具有家族性高胆固醇血症表型个体中的应用。
Gac Med Mex. 2024;160(4):413-419. doi: 10.24875/GMM.M24000918.
2
Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.与临床诊断为家族性高胆固醇血症的家族中多基因高胆固醇血症相关的单核苷酸变异
Rev Esp Cardiol (Engl Ed). 2018 May;71(5):351-356. doi: 10.1016/j.rec.2017.07.010. Epub 2017 Sep 14.
3
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia.12个单核苷酸多态性和6个单核苷酸多态性多基因评分对家族性高胆固醇血症患者高LDL-胆固醇水平易感性的影响。
Genes (Basel). 2024 Apr 6;15(4):462. doi: 10.3390/genes15040462.
4
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.治疗性单基因家族性高胆固醇血症与多基因高胆固醇血症患者的动脉粥样硬化更严重。
Atherosclerosis. 2017 Aug;263:405-411. doi: 10.1016/j.atherosclerosis.2017.05.015. Epub 2017 May 13.
5
An 8-SNP LDL Cholesterol Polygenic Score: Associations with Cardiovascular Risk Traits, Familial Hypercholesterolemia Phenotype, and Premature Coronary Heart Disease in Central Romania.一个包含 8 个单核苷酸多态性的 LDL 胆固醇多基因评分:与心血管风险特征、家族性高胆固醇血症表型和罗马尼亚中部的早发性冠心病的相关性。
Int J Mol Sci. 2024 Sep 18;25(18):10038. doi: 10.3390/ijms251810038.
6
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.用于临床家族性高胆固醇血症多基因形式诊断的低密度脂蛋白胆固醇遗传风险评分的变异选择优化及在6个国家样本中的验证
Clin Chem. 2015 Jan;61(1):231-8. doi: 10.1373/clinchem.2014.231365. Epub 2014 Nov 20.
7
Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction.全基因组测序分析早发性心肌梗死住院患者中单基因和多基因的作用。
Circulation. 2019 Mar 26;139(13):1593-1602. doi: 10.1161/CIRCULATIONAHA.118.035658.
8
Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?家族性高胆固醇血症:是否是时候将单基因家族性高胆固醇血症与多基因家族性高胆固醇血症区分开来了?
Curr Opin Lipidol. 2020 Jun;31(3):111-118. doi: 10.1097/MOL.0000000000000675.
9
Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.载脂蛋白 LDL-C 多基因 SNP 评分在家族性高胆固醇血症中的临床应用。
Atherosclerosis. 2018 Oct;277:457-463. doi: 10.1016/j.atherosclerosis.2018.06.006.
10
Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.临床确诊的高胆固醇血症的多基因与单基因病因
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2439-2445. doi: 10.1161/ATVBAHA.116.308027. Epub 2016 Oct 20.